Clinical Trial Update: Study of Lenalidomide and XRT in Patients With Newly Diagnosed Glioblastoma Multiforme [Phase 2]

View source ↗

Summary

A completed Phase 2 trial evaluating lenalidomide in combination with external beam radiation therapy for newly diagnosed glioblastoma multiforme.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Gliosarcoma
• Malignant Gliomas

Drugs mentioned

• External beam radiation therapy (XRT)
• Lenalidomide (lenalidomide)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Glioblastoma, Gliosarcoma | Phase 2 | Status: COMPLETED